InfuSystem Holdings (INFU) Interest Expenses (2010 - 2026)
InfuSystem Holdings (INFU) posted Interest Expenses of $527000.0 for Q1 2026, up 11.65% on a QoQ basis from $472000.0 in Q4 2025, and down 14.31% year-over-year from $615000.0 in Q1 2025.
InfuSystem Holdings (INFU) Interest Expenses (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Interest Expenses history runs 17 years deep, the most recent figure standing at $527000.0 for Q1 2026.
- Quarterly Interest Expenses fell 14.31% year-over-year to $527000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $527000.0 (down 74.64% YoY) and the FY2025 annual result came in at $2.0 million, up 3.05% from the prior year.
- Interest Expenses was $527000.0 for Q1 2026 at InfuSystem Holdings, up from $472000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $8.5 million in Q2 2025 and bottomed at $310000.0 in Q4 2022.
- A 5-year average of $979470.6 and a median of $524000.0 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses slumped 35.31% — and 2025, when it surged 1593.0%.
- InfuSystem Holdings' Interest Expenses stood at $310000.0 in 2022, then surged by 51.61% to $470000.0 in 2023, then slipped by 1.49% to $463000.0 in 2024, then grew by 1.94% to $472000.0 in 2025, then rose by 11.65% to $527000.0 in 2026.
- Business Quant data shows INFU's Interest Expenses at $527000.0 in Q1 2026, $472000.0 in Q4 2025, and $527000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 527,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 527,000.00 |
| Mar 31, 2026 | 527,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 527,000.00 |
| Sep 30, 2025 | 527,000.00 |
| Jun 30, 2025 | 8.47 Mn |
| Jun 30, 2025 | 8.47 Mn |
| Mar 31, 2025 | 615,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | 463,000.00 |
| Dec 31, 2024 | 463,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 530,000.00 |
| Mar 31, 2024 | 530,000.00 |
| Dec 31, 2023 | 470,000.00 |
| Dec 31, 2023 | 470,000.00 |